srpt stock price — quick guide

SRPT (Sarepta Therapeutics) — Stock price

SRPT stock price refers to the market price of shares of Sarepta Therapeutics, Inc., which trades on the NASDAQ under the ticker SRPT. This article covers how the SRPT stock price is reported, what moves it, historical performance, standard market metrics, ownership patterns, analyst coverage and practical ways to track the quote in real time. It is written for beginners and investors seeking a factual, sourceable reference.

Company overview

Sarepta Therapeutics, Inc. is a U.S.-based biotechnology company focused on RNA-targeted therapeutics and gene therapy approaches for rare neuromuscular diseases, most notably Duchenne muscular dystrophy (DMD). Headquartered in Cambridge, Massachusetts, Sarepta develops treatments through clinical programs, regulatory submissions and commercial launches for approved products.

Corporate developments — clinical trial readouts, regulatory decisions, label expansions, manufacturing updates, and commercial results — commonly produce large day-to-day moves in the SRPT stock price. Because Sarepta operates in the biotech sector, news flow tied to science and regulation tends to create above-average volatility when compared with large-cap, diversified companies.

Listing and ticker information

• Exchange: NASDAQ (United States)
• Ticker symbol: SRPT
• Trading currency: USD
• Typical trading hours (regular session): 09:30–16:00 ET
• Pre-market and post-market sessions: many data vendors report quotes for pre-market (often starting 04:00–08:00 ET) and after-hours (16:00–20:00 ET); these sessions can show wider spreads and thinner liquidity.
• Identifiers: company filings and data providers list CUSIP and ISIN codes for institutional reference; check Sarepta investor relations or SEC filings for the exact identifiers used by brokers and custodians.

Note: If you plan to trade SRPT, confirm your broker’s displayed timezone and whether the platform shows pre-/post-market quotes.

How SRPT stock price is reported

Real-time vs delayed quotes

• Real-time quotes deliver the latest transaction price as trades occur; exchanges and licensed vendors provide these feeds to brokers and professionals.
• Delayed quotes are typically delayed by 15–20 minutes for public display on free portals.
• Common data providers and pages that show either real-time or delayed SRPT quotes include the company investor relations page, NASDAQ real-time feeds (for licensed users), Yahoo Finance, MarketWatch and many broker platforms.
• Broker platforms (including Bitget for equities where available, and many retail brokerages) may offer near real-time execution and streaming quotes; always confirm whether a displayed price is live or delayed.

Common market data points

When you look up SRPT stock price you will typically see a set of standard fields. Common fields include:

• Last price: the most recent traded price.
• Change / % change: difference versus prior session close and the percentage move.
• Bid and ask: highest price buyers are willing to pay (bid) and lowest price sellers will accept (ask) — important for understanding the current spread and immediate execution costs.
• Size at bid/ask: number of shares available at the quoted bid/ask levels.
• Volume: shares traded during the current session; average daily volume is usually reported separately.
• 52-week high / low: the highest and lowest traded prices in the past 52 weeks.
• Market capitalization: shares outstanding multiplied by price — a snapshot measure of company size.
• Shares outstanding and float: total shares and the portion available for trading.
• P/E ratio and EPS: for profitable companies these are widely used; many biotechs have negative EPS, so P/E may be not meaningful.
• Beta: volatility measure versus a benchmark (e.g., S&P 500).

Each of these metrics helps contextualize the SRPT stock price and how cheaply or expensively the market values the company in a comparative sense.

Historical price performance

Sarepta’s history shows periods of dramatic appreciation and sharp drawdowns — a common pattern for clinical-stage and commercial-stage biotechs.

• Long-term investors will often review multi-year charts to see how the SRPT stock price reacted to major regulatory milestones (approvals, label changes), trial results, and commercial launches.
• Short- and medium-term traders focus on daily and intraday price action around catalysts.

Where to access historical data: Yahoo Finance provides downloadable daily and intraday price series; NASDAQ historical quotes include official trade records; YCharts and MarketWatch offer charting and key statistics. For regulatory events and validated timestamps, the company’s SEC filings and press releases are primary sources.

Recent price drivers and notable events

Biotech equities like Sarepta are highly sensitive to company-specific catalysts. Typical drivers of SRPT stock price include:

• Clinical trial data readouts (Phase 2/3 outcomes or long-term follow-ups).
• FDA and other regulatory agency decisions, advisory committee outcomes and label changes.
• Commercial performance and quarterly revenue results tied to approved therapies.
• Manufacturing or supply updates that affect product availability.
• Strategic partnerships, licensing deals, M&A interest or pipeline divestitures.
• Legal and intellectual property outcomes, including patent decisions.
• Larger sector moves or macro events (risk-off markets, interest-rate shifts) that affect biotech valuations broadly.

Examples of past catalysts

• Trial readouts or confirmatory study announcements: historically, Sarepta press releases about Phase 3 or confirmatory trial data have led to significant intraday moves in the SRPT stock price.
• Regulatory milestones: approvals or regulatory setbacks can generate multi-day rallies or selloffs.

As of January 27, 2026, according to Yahoo Finance and Benzinga, SRPT experienced a notable pre-market rally after Sarepta announced it would present three-year topline functional results from a Phase 3 study targeting Duchenne muscular dystrophy. News summaries reported a premarket move of about +6–7% with prices reported near $22.50–$22.60 per share on that day. These reported figures provide an example of how a clinical update can quickly affect the SRPT stock price.

Market and financial metrics

Investors and analysts focus on a set of quantifiable metrics when assessing the SRPT stock price. Typical metrics include:

• Market capitalization: calculated as last price × shares outstanding. Use updated shares outstanding from the latest SEC 10-Q/10-K.
• Average daily volume: gives a sense of liquidity; higher volume generally means easier execution.
• Float and shares outstanding: float is the tradable portion and affects volatility.
• Revenue and revenue growth: for biotechs with marketed products, quarterly revenue helps anchor commercial progress.
• EPS and adjusted EPS: many development-stage biotechs show negative GAAP EPS; adjusted or non-GAAP metrics may be shown in analyst reports.
• P/E ratio: may be not meaningful if EPS is negative.
• Beta and volatility statistics: indicate historical sensitivity to market moves.

Primary data sources for these metrics: company investor relations pages, SEC filings, NASDAQ summary pages, Yahoo Finance, MarketWatch and YCharts. For the most current SRPT stock price and derived metrics, consult a real-time data feed or an active broker platform.

Ownership and trading activity

Institutional holders

Institutional ownership (mutual funds, pension funds, hedge funds) can materially affect share liquidity and stability. Heavy institutional ownership sometimes reduces free float and can amplify moves when institutions rebalance positions.

Investors can review 13F filings and aggregated institutional-holding summaries on financial data providers to see which institutions hold sizeable SRPT positions. Institutional changes — new buys or large sales — often surface in quarterly filings and may correlate with periods of reduced or increased volume.

Insider transactions and executive holdings

Insider trades (executive or director buying/selling) are filed with the SEC and are publicly visible. Insider purchasing can be interpreted by some market participants as a confidence signal, while insider selling may reflect diversification or personal liquidity needs. For SRPT, check the company’s Form 4 filings on the SEC EDGAR system and cross-check summaries on major finance pages for recent insider activity.

Both institutional and insider transaction data are important inputs when reviewing the SRPT stock price dynamics, but neither should be interpreted in isolation.

Analyst coverage and market sentiment

Analysts issue research notes with ratings (e.g., Buy, Hold, Sell) and price targets. Changes in coverage, rating downgrades or upgrades, and new price targets can nudge the SRPT stock price, especially around catalyst windows.

Consensus estimates and analyst price targets are available on mainstream data portals such as Yahoo Finance and MarketWatch, as well as in broker reports. Track the publication date and the assumptions behind coverage (e.g., uptake curves for therapies, pricing assumptions, patient-population estimates) when reviewing analyst-driven impacts on the SRPT stock price.

Market sentiment indicators — short interest, put/call ratios and options activity — can also foreshadow heightened volatility around anticipated events.

Risks and volatility

Sector-specific and company-specific risks that influence the SRPT stock price include:

• Clinical and regulatory risk: negative trial outcomes or unfavorable regulatory feedback can sharply reduce valuation.
• Commercial execution: slower-than-expected reimbursement, market uptake or manufacturing constraints weigh on revenue projections.
• Patent and intellectual property challenges: litigation or patent losses may reduce exclusive market rights.
• Financing risk: biotechs may need periodic capital raises; dilution from secondary offerings can pressure the SRPT stock price.
• Market and macro risk: changes in interest rates, credit conditions, and broad risk sentiment can compress biotech multiples.

Biotech equities, including Sarepta, typically show elevated short-term volatility relative to large-cap, diversified stocks. That makes position sizing and risk management particularly important for traders. This article is informational and not investment advice.

How to track SRPT stock price

Reliable sources and tools:

• Company investor relations: firms often publish stock quote snapshots, filings and press releases; use this for official corporate announcements.
• NASDAQ real-time pages: official exchange data and post-trade summaries.
• Major financial portals: Yahoo Finance and MarketWatch provide quick access to charts, historical data, and news feeds (note: some data may be delayed).
• YCharts and financial terminals: for institutional-grade charts and analytics.
• Broker platforms: for real-time execution and streaming quotes in your account (Bitget’s platform for supported equities is recommended within this article’s context).
• SEC filings (EDGAR): for validated corporate disclosures, insider transactions, and shares outstanding.

When monitoring SRPT stock price, check whether the displayed quote is real-time or delayed and confirm the session (pre-market, regular, after-hours) for correct interpretation.

Trading considerations

• Liquidity: check average daily volume and current bid-ask spreads before placing market orders. Thin pre- or post-market sessions can yield wider spreads and unfavorable fills.
• Limit orders: use limit orders to control execution price, especially in volatile biotech names like SRPT.
• Pre-/post-market trading: price moves outside regular hours may reflect early reactions to news and can be more volatile.
• Options availability: if SRPT options trade on your derivatives platform, options activity (open interest, implied volatility) can reflect expected future moves.
• Risk management: due to higher volatility, many traders use position sizing rules and stop limits to control downside risk.

Remember: this section is educational — not a recommendation to buy, sell or hold any security.

Timeline of major price-impacting events (selected)

Note: the timeline below lists types of events that historically move SRPT stock price. For each entry, the primary verification source is listed (company press releases, SEC filings, or major financial news). Populate exact dates and outcomes by consulting the company’s press archive and SEC filing history for precise timestamps.

• [Date: verify in filings] — Major Phase 3 trial topline readout announced (typically large intraday move). Source: Sarepta press release / clinicaltrials updates.
• [Date: verify in filings] — FDA approval or label decision for a marketed therapy (material rally or drop depending on outcome). Source: FDA announcement, company IR.
• [Date: verify in filings] — Confirmatory trial completion or presentation at a major medical conference (e.g., three-year topline functional results presentation). Source: Company release announced Jan 2026; market reaction observed Jan 27, 2026 (reported by Yahoo Finance/Benzinga).
• [Date: verify in filings] — Quarterly earnings and guidance updates (commonly move price on reported revenue or forward guidance). Source: Company 10-Q or press release.
• [Date: verify in filings] — Manufacturing or supply-chain disruption reported (can temporarily depress commercial expectations). Source: Company IR and regulatory letters.

For a fully populated timeline with exact dates and links to SEC exhibits, consult the company investor relations archive and EDGAR filings.

See also

• Sarepta Therapeutics (company profile and pipeline overview)
• NASDAQ (market structure and quote types)
• Biotech investing basics (clinical phases, regulatory timeline)
• Stock price data providers (how to read and verify quotes)

References and data sources

Primary sources recommended for SRPT stock price verification and event confirmation:

• Sarepta Investor Relations and press release archive (company announcements, SEC filings)
• NASDAQ summary and real-time data pages (market trades and official exchange data)
• Yahoo Finance SRPT quote and news pages (charts, historical data, news aggregation)
• MarketWatch SRPT company and quote pages
• Robinhood SRPT summary (broker view of quote and news for retail investors)
• YCharts for charts and key statistics
• SEC EDGAR filings (10-K, 10-Q, Form 4 insider transactions) for authoritative, time-stamped disclosures
• Benzinga and major financial news coverage for near-real-time market reporting

As of January 27, 2026, major outlets reported a premarket SRPT move of roughly +6–7% after Sarepta announced it would present three-year topline functional results from a Phase 3 study in Duchenne muscular dystrophy. Price snapshots published on that day by Benzinga and Yahoo Finance showed SRPT trading near USD 22.50–22.60 per share during pre-market coverage. These reports were widely circulated by market news desks and reflect a concrete example of how clinical news affects the SRPT stock price.

Practical checklist to verify SRPT stock price before acting

1. Confirm the quote is real-time (not delayed by 15–20 minutes).
2. Check whether the price shown is from regular hours or pre-/post-market.
3. Review the latest company press release for any corporate disclosures that explain recent moves.
4. Scan recent SEC filings (Form 8-K, 10-Q) for material events or forward guidance changes.
5. Look at volume and bid-ask spread to judge liquidity at the current price.
6. Check institutional-ownership summaries and recent 13F/insider filings if ownership changes could affect liquidity.

Frequently asked questions (FAQ)

Q: Where can I get the most up-to-date SRPT stock price? A: For execution and real-time quotes use a broker platform that provides live NASDAQ feeds. For quick public reference, NASDAQ real-time pages and major financial portals like Yahoo Finance and MarketWatch display SRPT quotes; verify whether those quotes are real-time or delayed.

Q: Why does SRPT stock price sometimes jump in pre-market trading? A: Pre-market jumps usually follow overnight press releases, conference presentations, or international news. Pre-market liquidity is lower, so smaller volume can move the SRPT stock price more sharply.

Q: What metrics should I watch for Sarepta? A: Key metrics include market capitalization, revenue growth for any commercial products, average daily volume, shares outstanding/float, trial-readout timelines, and cash runway. For more detailed ratios, use reported revenue and EPS from 10-Q/10-K filings.

Final notes and how Bitget can help

Tracking SRPT stock price requires timely, accurate data and tools that let you view both market quotes and the corporate disclosures that explain them.

• For traders and investors who prefer an integrated platform, Bitget offers market data, trading tools and secure account features suitable for actively monitoring equities where supported. (If you choose a trading platform, confirm whether SRPT is available and whether your region supports equity trading on that platform.)
• For custody and wallet needs related to Web3 holdings mentioned alongside market commentary, Bitget Wallet is recommended within this article’s context as a secure option for on-chain assets.

This article is informational. It provides sources and a framework to understand the SRPT stock price but does not constitute investment advice.